// App-Quantinova.ai

2197 : Health-Related Quality of Life in Children with Chronic Immune Thrombocytopenia Treated with Eltrombopag in the PETIT Study.

Researchers

Presenter

  • Kelly M Grotzinger

Principal Investigators

  • Lisa Marcello

  • Kalpana Bakshi

  • Andres Brainsky

Medical Centers

  • Hospital for Sick Children, Toronto, ON, Canada

Locations

  • Canada

Companies

  • GlaxoSmithKline plc.

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Immune thrombocytopenia

Biomarkers

  • KIT Proto-Oncogene, Receptor Tyrosine Kinase

Drug/Treatment

  • Eltrombopag

Outcome

  • N/A

Study Design

  • open label

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved